The expression profile of ATP-binding cassette transporter genes in breast carcinoma
Language English Country Great Britain, England Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
23556449
DOI
10.2217/pgs.13.26
Knihovny.cz E-resources
- MeSH
- ATP-Binding Cassette Transporters genetics metabolism MeSH
- Genetic Association Studies MeSH
- Carcinoma drug therapy genetics pathology MeSH
- Middle Aged MeSH
- Humans MeSH
- Breast Neoplasms drug therapy genetics pathology MeSH
- Neoadjuvant Therapy MeSH
- Antineoplastic Agents administration & dosage MeSH
- Gene Expression Regulation, Neoplastic MeSH
- Gene Expression Profiling MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- ATP-Binding Cassette Transporters MeSH
- Antineoplastic Agents MeSH
AIM: ATP-binding cassette (ABC) transporters contribute to development of resistance to anticancer drugs via ATP-dependent drug efflux. A major goal of our study was to investigate associations between the expression of ABC transporters and outcome of breast carcinoma patients. PATIENTS & METHODS: Transcript levels of all 49 human ABC transporters were determined in post-treatment tumor and non-neoplastic tissue samples from 68 breast carcinoma patients treated by neoadjuvant chemotherapy. Six ABC transporters were then evaluated in independent series of 100 pretreatment patients. RESULTS: ABCA5/6/8/9/10, ABCB1/5/11, ABCC6/9, ABCD2/4, ABCG5 and ABCG8 were significantly downregulated and ABCA2/3/7/12, ABCB2/3/8/9/10, ABCC1/4/5/10/11/12, ABCD1/3, ABCE1, ABCF1/2/3 and ABCG1 were upregulated in post-treatment tumors compared with non-neoplastic tissues. Significant associations of intratumoral levels of ABCC1 and ABCC8 with grade and expression of hormonal receptors were found in both sets of patients. ABCA12, ABCA13 and ABCD2 levels were significantly associated with the response to neoadjuvant chemotherapy in post-treatment patients. Protein expression of ABCA12, ABCC8 and ABCD2 in tumor tissues of patients with breast carcinoma was observed by immunoblotting for the first time. CONCLUSION: ABCA12, ABCA13, ABCC1, ABCC8 and ABCD2 present potential modifiers of progression and response to the chemotherapy of breast carcinoma.
References provided by Crossref.org
Effects of 7-ketocholesterol on tamoxifen efficacy in breast carcinoma cell line models in vitro
Role of Genetic Variation in Cytochromes P450 in Breast Cancer Prognosis and Therapy Response
SLC46A1 Haplotype with Predicted Functional Impact has Prognostic Value in Breast Carcinoma
Role of Genetic Variation in ABC Transporters in Breast Cancer Prognosis and Therapy Response
ABC Transporters and Their Role in the Neoadjuvant Treatment of Esophageal Cancer
Molecular profile of 5-fluorouracil pathway genes in colorectal carcinoma
The role of cytochromes p450 and aldo-keto reductases in prognosis of breast carcinoma patients